BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
-
Mexican car industry fears higher tariffs on China will drive its demise
-
Battle brews over Australia or Turkey hosting next COP
-
Hansen and Prendergast start for Ireland against Australia
-
McIlroy two shots off the lead as Kim top after round one in Dubai
-
Stocks sluggish as US government shutdown ends
-
De Minaur knocks out Fritz to keep ATP Finals hopes alive
-
Ikitau and O'Connor return as Wallabies make changes for Ireland
-
EU backs small parcel duties to tackle China import flood
-
Europe court orders Poland pay damages to woman who aborted abroad
-
EU lawmakers back proxy voting for pregnant women, new mothers
-
England great Anderson to play on for Lancashire
-
Swiss economy minister back in Washington for tariff talks
-
Race for first private space station heats up as NASA set to retire ISS
-
France lifts travel ban on Telegram founder Durov
-
Quesada sticks with Italy's Wallabies heroes for Springboks Test
-
Amazon robotics lead casts doubt on eye-catching humanoids
-
Springboks ring changes for Italy clash
-
How embracing 'ickiness' helped writer Szalay win Booker Prize
-
World oil market 'lopsided' as supply outpaces demand: IEA
-
Alldritt 'takes up the torch' for France against Fiji after South Africa loss
-
Hitler likely had genetic condition limiting sexual development: research
-
Zelensky sanctions associate as corruption scandal engulfs Kyiv
-
Germany agrees to keep military service voluntary
-
Japan PM Takaichi says she sleeps only 2-4 hours a night
-
South Africa announces plan to bid for Olympic Games
-
Juan Ponce Enrile, architect of Philippines martial law, dies at 101
-
Stocks waver as US government shutdown ends
-
Google to pay millions to South African news outlets: watchdog
-
EU probes Google over news site rankings despite Trump threats
-
Pakistan grants lifetime immunity to president, current army chief
-
South Africa's Bavuma says winning in India top ambition
-
Alldritt back to captain France against Fiji after South Africa loss
-
Juan Ponce Enrile, architect of Philippine martial law, dies at 101: daughter
-
'Ready' Rees-Zammit back in Wales's starting team to face Japan
-
Spinners decide Tests in India, Gill says before South Africa opener
-
K-pop group NewJeans ends feud with record label ADOR
-
Asian stocks rise with focus on Fed, tech as US government reopens
-
UK economic gloom deepens before budget
-
Scott Barrett returns to skipper All Blacks against England
-
Burberry narrows first half loss on turnaround plan
-
Sri Lanka to stay in Pakistan after bomb, games move to Rawalpindi
-
Zanzibar women turn to sponge farming as oceans heat up
-
Stocks rise with focus on Fed, tech as US government reopens
-
Curry lifts Warriors over Spurs, Thunder rout Lakers, Jokic shines
-
Mushroom material takes on plastic packaging at Belgian start-up
-
India's top tennis player says denied China visa
-
In Kyrgyzstan, world's largest natural walnut forest thins away
-
TV soaps and diplomacy as Bangladesh and Turkey grow closer
-
Striking Boeing defense workers to vote on latest contract
-
Australia's opposition ditches commitment to net zero emissions
NYSE - LSE
| RBGPF | -0.06% | 78.47 | $ | |
| GSK | 0.74% | 48.43 | $ | |
| NGG | 0.13% | 78.128 | $ | |
| RIO | 0.49% | 71.46 | $ | |
| BTI | -1.43% | 55.035 | $ | |
| SCS | 0.06% | 15.76 | $ | |
| RYCEF | -0.47% | 14.96 | $ | |
| CMSC | -0.29% | 24.01 | $ | |
| VOD | 0.88% | 12.48 | $ | |
| RELX | 0.71% | 41.655 | $ | |
| BP | 0.26% | 36.955 | $ | |
| BCE | 0.98% | 22.995 | $ | |
| CMSD | -0.68% | 24.385 | $ | |
| BCC | 0.3% | 70.49 | $ | |
| AZN | 1.18% | 88.725 | $ | |
| JRI | -0.65% | 13.78 | $ |
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
WESTMINSTER, CA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Friday, November 14th, 2025, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending September 30th, 2025, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: | 877-545-0320 |
Teleconference International: Participant Access Code: | +1-973-528-0002 517720 |
To watch or listen to a replay of the webcast or teleconference:
Teleconference Replay Expiration: | Sunday, February 14th, 2027 |
Teleconference Replay Domestic: | 877-481-4010 |
Teleconference Replay International: | 919-882-2331 |
Replay Passcode: | 53245 |
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
L.Durand--AMWN
